Different miRNA signatures have been shown in critically ill COVID-19 patients as opposed to hospital-ward-treated patients, including altered miR-16-5p and miR-192-5p expression, which have been shown to associate with platelets and ADAMTS13, respectively [2, 3, 17, 23]. This evidence concerns the gene ADAMTS13 and COVID-19.